BioSpace News Archive

Business

Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022

Meridian Bioscience, Inc. will report first quarter 2022 financial results Friday, February 4, 2022.

January 10, 2022
·
1 min read
Animal Ultrasound Market Size to Reach USD 532.5 Million in 2028 Growing at a CAGR of 8.2%

According to Emergen Research, the global animal ultrasound market size was USD 286.2 Million in 2020 and is expected to reach USD 532.5 million in 2028 and register a revenue CAGR of 8.2% during the forecast period, 2021-2028.

January 10, 2022
·
7 min read
Dermal Regeneration Template Market Size to Reach USD 1,581.9 Million in 2028 Growing at a CAGR of 10.2%

According to Emergen Research, the global dermal regeneration template market size was USD 722.1 Million in 2020 and is expected to reach USD 1,581.9 Million in 2028 and register a revenue CAGR of 10.2% during the forecast period, 2021-2028.

January 10, 2022
·
6 min read
Business

NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, announced today the appointment of Todd P. Branning as Chief Financial Officer (CFO).

January 10, 2022
·
5 min read
Policy

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan’s Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra™ AV Transcatheter Pacing System (TPS), and the company will launch the product this month.

January 10, 2022
·
4 min read
Business

SomaLogic Announces Appointment of Adam Taich as Chief Business Officer

SomaLogic, a leader in data-driven proteomics technology, announced that Adam Taich has joined the company as the Chief Business Officer.

January 10, 2022
·
2 min read
Biotech Beach

Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference

Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed today the company’s strong growth trajectory, including 2021 results and 2022 guidance.

January 10, 2022
·
10 min read
Biotech Bay

Rigel to Present at the J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company’s president and chief executive officer, is scheduled to present a company overview at the 40th Annual J.P. Morgan Healthcare Conference at 10:30 a.m. ET on Wednesday, January 12, 2022.

January 10, 2022
·
2 min read
Business

Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care

Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing.

January 10, 2022
·
4 min read
Business

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2021 Financial Results

Zimmer Biomet Holdings, Inc. announced its fourth quarter earnings conference call will be webcast on Monday, February 7, 2022 at 8:30 a.m. ET.

January 10, 2022
·
1 min read